98 related articles for article (PubMed ID: 25307864)
1. Nuclear expression of histone deacetylases and their histone modifications predicts clinical outcome in colorectal cancer.
Benard A; Goossens-Beumer IJ; van Hoesel AQ; Horati H; de Graaf W; Putter H; Zeestraten EC; Liefers GJ; van de Velde CJ; Kuppen PJ
Histopathology; 2015 Jan; 66(2):270-82. PubMed ID: 25307864
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
[TBL] [Abstract][Full Text] [Related]
3. Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer.
Al-Sohaily S; Henderson C; Selinger C; Pangon L; Segelov E; Kohonen-Corish MR; Warusavitarne J
Histopathology; 2014 Aug; 65(2):155-63. PubMed ID: 24118100
[TBL] [Abstract][Full Text] [Related]
4. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
[TBL] [Abstract][Full Text] [Related]
5. Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer.
Benard A; Goossens-Beumer IJ; van Hoesel AQ; de Graaf W; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
BMC Cancer; 2014 Jul; 14():531. PubMed ID: 25047223
[TBL] [Abstract][Full Text] [Related]
6. Global histone modification patterns as prognostic markers to classify glioma patients.
Liu BL; Cheng JX; Zhang X; Wang R; Zhang W; Lin H; Xiao X; Cai S; Chen XY; Cheng H
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2888-96. PubMed ID: 20978174
[TBL] [Abstract][Full Text] [Related]
7. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
8. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
[TBL] [Abstract][Full Text] [Related]
9. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
10. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
Jang SH; Min KW; Paik SS; Jang KS
J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
[TBL] [Abstract][Full Text] [Related]
11. Opposing prognostic roles of nuclear and cytoplasmic RACGAP1 expression in colorectal cancer patients.
Yeh CM; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chang WH; Chen CY; Ko JL; Chen CJ
Hum Pathol; 2016 Jan; 47(1):45-51. PubMed ID: 26508373
[TBL] [Abstract][Full Text] [Related]
12. Prognostic correlation between MTA2 expression level and colorectal cancer.
Ding W; Hu W; Yang H; Ying T; Tian Y
Int J Clin Exp Pathol; 2015; 8(6):7173-80. PubMed ID: 26261611
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic significance of annexin A2 in colorectal cancer.
Yang T; Peng H; Wang J; Yang J; Nice EC; Xie K; Huang C
Colorectal Dis; 2013 Jul; 15(7):e373-81. PubMed ID: 23489866
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
Formentini A; Henne-Bruns D; Kornmann M
Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
[TBL] [Abstract][Full Text] [Related]
15. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of integrin αv correlates with poor prognosis in colorectal cancer.
Ha SY; Shin J; Kim JH; Kang MS; Yoo HY; Kim HH; Um SH; Kim SH
J Clin Pathol; 2014 Jul; 67(7):576-81. PubMed ID: 24695839
[TBL] [Abstract][Full Text] [Related]
17. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
18. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
[TBL] [Abstract][Full Text] [Related]
19. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
20. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
